Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Cancer Drug Resistance (Alhambra, Calif.)|February 6, 2024
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancerMasahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2011
[A case of primary cardiac angiosarcoma associated with cardiac tamponade]Naoki Nakaya, Itaru Sato, Takeo Shimasaki, et al.
Oncology Reports|September 11, 2012
Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitroTakanobu Takata, Yasuhito Ishigaki, Takeo Shimasaki, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 21, 2009
An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 betaKatsuyoshi Miyashita, Mitsutoshi Nakada, Abbas Shakoori, et al.
Cancer Science|August 4, 2016
Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapyTakahiro Domoto, Ilya V Pyko, Takuya Furuta, et al.
Molecular and Cellular Biochemistry|January 6, 2016
Regulation of soluble Flt-1 (VEGFR-1) production by hnRNP D and protein arginine methylationTakayuki Ikeda, Yasuo Yoshitomi, Hidehito Saito, et al.
Molecular Medicine Reports|November 6, 2013
The *1244 A>G polymorphism of MyD88 (rs7744) is closely associated with susceptibility to ulcerative colitisKazuhiro Matsunaga, Tomomitsu Tahara, Hisakazu Shiroeda, et al.
Pageof 5